Form 8-K - Current report:
SEC Accession No. 0001104659-25-100264
Filing Date
2025-10-17
Accepted
2025-10-17 08:08:41
Documents
38
Period of Report
2025-10-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plx-20251017x8k.htm   iXBRL 8-K 41955
2 EX-99.1 plx-20251017xex99d1.htm EX-99.1 36967
3 EX-99.2 plx-20251017xex99d2.htm EX-99.2 35906
4 GRAPHIC plx-20251017xex99d1g001.jpg GRAPHIC 128782
5 GRAPHIC plx-20251017xex99d1g002.jpg GRAPHIC 287742
6 GRAPHIC plx-20251017xex99d1g003.jpg GRAPHIC 195720
7 GRAPHIC plx-20251017xex99d1g004.jpg GRAPHIC 94666
8 GRAPHIC plx-20251017xex99d1g005.jpg GRAPHIC 156214
9 GRAPHIC plx-20251017xex99d1g006.jpg GRAPHIC 112262
10 GRAPHIC plx-20251017xex99d1g007.jpg GRAPHIC 103745
11 GRAPHIC plx-20251017xex99d1g008.jpg GRAPHIC 101857
12 GRAPHIC plx-20251017xex99d1g009.jpg GRAPHIC 103873
13 GRAPHIC plx-20251017xex99d1g010.jpg GRAPHIC 140901
14 GRAPHIC plx-20251017xex99d1g011.jpg GRAPHIC 114850
15 GRAPHIC plx-20251017xex99d1g012.jpg GRAPHIC 110907
16 GRAPHIC plx-20251017xex99d1g013.jpg GRAPHIC 108425
17 GRAPHIC plx-20251017xex99d1g014.jpg GRAPHIC 122514
18 GRAPHIC plx-20251017xex99d1g015.jpg GRAPHIC 172485
19 GRAPHIC plx-20251017xex99d1g016.jpg GRAPHIC 160078
20 GRAPHIC plx-20251017xex99d1g017.jpg GRAPHIC 146678
21 GRAPHIC plx-20251017xex99d1g018.jpg GRAPHIC 134746
22 GRAPHIC plx-20251017xex99d1g019.jpg GRAPHIC 147947
23 GRAPHIC plx-20251017xex99d1g020.jpg GRAPHIC 125686
24 GRAPHIC plx-20251017xex99d1g021.jpg GRAPHIC 99257
25 GRAPHIC plx-20251017xex99d1g022.jpg GRAPHIC 126455
26 GRAPHIC plx-20251017xex99d2001.jpg GRAPHIC 10659
27 GRAPHIC plx-20251017xex99d2002.jpg GRAPHIC 5450
  Complete submission text file 0001104659-25-100264.txt   4391512

Data Files

Seq Description Document Type Size
28 EX-101.SCH plx-20251017.xsd EX-101.SCH 2895
29 EX-101.LAB plx-20251017_lab.xml EX-101.LAB 16017
30 EX-101.PRE plx-20251017_pre.xml EX-101.PRE 10762
40 EXTRACTED XBRL INSTANCE DOCUMENT plx-20251017x8k_htm.xml XML 4912
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 251399010
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)